You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic head and neck cancer

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Melanoma, Metastatic Breast Cancer, Advanced Renal Cell Carcinoma Trial in Worldwide (single arm)

Withdrawn
  • Metastatic Melanoma
  • +5 more
  • single arm
  • (no location specified)
Dec 20, 2022

Head and Neck Squamous Cell Carcinoma, Metastatic Squamous Cell Carcinoma Trial in Edmonton, London, Montréal (SBRT, Durvalumab,

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Metastatic Squamous Cell Carcinoma
  • SBRT
  • +2 more
  • Edmonton, Alberta, Canada
  • +2 more
Mar 14, 2022

Head Neck Cancer, Squamous Cell Carcinoma Trial in London (Avelumab, Cetuximab)

Active, not recruiting
  • Head and Neck Cancer
  • Squamous Cell Carcinoma
  • London, United Kingdom
    University College Hospital
May 17, 2022

Recurrent Cancer, Metastatic Cancer, Advanced Malignancies Trial (INCAGN01876, retifanlimab)

Recruiting
  • Recurrent Cancer
  • +3 more
  • INCAGN01876
  • retifanlimab
  • Birmingham, Alabama
  • +17 more
Dec 13, 2022

Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC) Trial in United States (pepinemab + pembrolizumab)

Recruiting
  • Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)
  • pepinemab + pembrolizumab
  • Springdale, Arkansas
  • +17 more
Dec 7, 2022

Advanced Solid Tumor, Metastatic Colorectal Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Irvine, Chicago, Boston

Not yet recruiting
  • Advanced Solid Tumor
  • +4 more
  • Irvine, California
  • +2 more
Nov 27, 2023

Head Neck Cancer, Metastatic Cancer, Oligoprogressive Trial in Montréal (Standard arm, Experimental arm)

Recruiting
  • Head and Neck Cancer
  • +2 more
  • Standard arm
  • Experimental arm
  • Montréal, Quebec, Canada
    Centre Hospitalier de l'Université de Montréal
Mar 6, 2022

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

Recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +24 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 18, 2022

Blood Tests and Questionnaires in Studying Adherence to

Recruiting
  • Carcinoma of Unknown Primary
  • +30 more
  • Biospecimen Collection
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Dec 12, 2022

Malignant Tumor in the Head and Neck, Metastatic Malignant Tumor in the Head and Neck Trial in Seattle (other, procedure, drug)

Not yet recruiting
  • Malignant Neoplasm in the Head and Neck
  • Metastatic Malignant Neoplasm in the Head and Neck
  • Iodixanol
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 11, 2022

Head Neck Cancer, Advanced Cancer, Metastatic Cancer Trial in Bordeaux, Lyon, Nice (Abemaciclib)

Recruiting
  • Head and Neck Cancer
  • +2 more
  • Bordeaux, France
  • +2 more
Jul 22, 2022

Head and Neck Tumors Trial in Tainan, Taipei (SCB01A)

Terminated
  • Head and Neck Neoplasms
  • Tainan, Taiwan
  • +3 more
Jun 22, 2022

Head and Neck Squamous Cell Carcinoma Trial in Norfolk, Omaha (Capecitabine, Docetaxel, Quality-of-Life Assessment)

Terminated
Has Results
  • Head and Neck Squamous Cell Carcinoma
  • Norfolk, Nebraska
  • +2 more
Aug 10, 2022

Advanced Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head-and-neck

Recruiting
  • Advanced Head and Neck Squamous Cell Carcinoma
  • +5 more
  • Pembrolizumab (immunotherapy)
  • Quad-shot palliative radiotherapy
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Feb 7, 2022

Circulating Tumor DNA Kinetics in Immuno-oncology

Completed
  • Head and Neck Cancer
  • +4 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    May 16, 2022

    Advanced Head and Neck Squamous Cell Carcinoma, Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma Trial in

    Recruiting
    • Advanced Head and Neck Squamous Cell Carcinoma
    • +14 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Indianapolis, Indiana
    • +4 more
    Aug 19, 2022

    Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in

    Not yet recruiting
    • Head and Neck Cancer
    • +8 more
    • Tumor and HLA Profiling
    • (no location specified)
    Mar 31, 2023

    Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck Trial in Tucson, Tampa

    Terminated
    Has Results
    • Cutaneous Squamous Cell Carcinoma
    • Cutaneous Squamous Cell Carcinoma of the Head and Neck
    • Tucson, Arizona
    • +1 more
    Nov 2, 2022

    Head Neck Cancer Trial in Madison (NKTR-214, anti-PD-1 therapy, Palliative Radiation)

    Active, not recruiting
    • Head and Neck Cancer
    • Madison, Wisconsin
      University of Wisconsin
    May 9, 2022

    Head and Neck Tumor Trial in Milwaukee (50 Gy Radiation Therapy, 55 Gy Radiation Therapy, 60 Gy Radiation Therapy)

    Recruiting
    • Head and Neck Neoplasm
    • 50 Gy Radiation Therapy
    • +3 more
    • Milwaukee, Wisconsin
      Froedtert & Medical College of Wisconsin
    Apr 21, 2022

    Head and Neck Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, Head Neck Cancer Trial in United States (Lenvatinib

    Completed
    • Head and Neck Squamous Cell Carcinoma
    • +3 more
    • Basking Ridge, New Jersey
    • +6 more
    Oct 13, 2022

    Head and Neck Squamous Cell Carcinoma Trial in La Jolla (Avelumab, Palbociclib, Cetuximab)

    Active, not recruiting
    • Head and Neck Squamous Cell Carcinoma
    • La Jolla, California
      UC San Diego Moores Cancer Center
    Feb 16, 2022

    Squamous Cell Carcinoma of the Head and Neck Trial in Pittsburgh (Nivolumab+Relatlimab, Nivolumab+Ipilimumab)

    Recruiting
    • Squamous Cell Carcinoma of the Head and Neck
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Jul 13, 2022

    Head and Neck Squamous Cell Carcinoma Trial in Seoul (nivolumab-GX-188E-GX-I7)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Apr 20, 2022

    Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Seattle (biological,

    Terminated
    • Metastatic Head and Neck Squamous Cell Carcinoma
    • Recurrent Head and Neck Squamous Cell Carcinoma
    • Durvalumab
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Feb 23, 2022